George Steuart Health announced its renewed partnership with the TIL Healthcare, India for the marketing and distribution of TIL Healthcare products in Sri Lanka.
TIL Healthcare, formerly known as Tablets India was originally launched with George Steuart in the mid-90s. This renewed partnership will make the availability of a range of amino acids and probiotics to the market. Bifilac, the pioneer probiotic, is also set to be reintroduced to the market through this synergy.
Probiotics are live microorganisms that are intended to have health benefits when consumed or applied to the body. They can help maintain homeostasis within the gut microbiota, providing a wide range of health benefits. At present, it is a worldwide trend to incorporate probiotics to the daily diet in fermented foods. The benefits of probiotics to the cereal-based Sri Lankan diet has also been studied. Bifilac offers a combination of good bacteria as well as yeast, which is introduced in the intestine intentionally to balance the microbial flora internal environment) of the intestine.
TIL Healthcare is the international pharmaceutical arm of the Jhaver Group of companies. The group currently has five pharmaceutical formulation manufacturing facilities offering various products in liquids, capsules, tablets, injectables, soft-gel, and powders. TIL Healthcare exports its products to over 54 countries spread across Asia, Africa, CIS, Central, and Latin America and is backed by strong infrastructure and technical personnel.
Kapil Jhaver, President/Managing Director, TIL Healthcare, noted that they are elated to partner with one of the fastest-growing companies in Sri Lanka. With their recently commissioned state-of-the-art manufacturing facility dedicated to global supplies, he stated that TIL healthcare is committed to further strengthen the partnership with George Steuart Health through new business opportunities.
Dilith Jayaweera, Group Chairman, George Steuart Company, said, As we celebrate our 185th anniversary this year, we recognize our greatest strength is our people and our partners. I congratulate TIL Healthcare and George Steuart Health and look forward to a fruitful partnership.”
George Steuart Health currently boasts a portfolio of pharmaceuticals, nutraceuticals, cosmodermaceuticals, medical equipment, as well as medical diagnostic devices.
“The addition of the TIL healthcare products, will further strengthen our basket and broaden our services to the healthcare sector,” commented Eran Ranasinghe, Executive Director, George Steuart Health. On the company’s re- newed partnership, he commented “We are happy to reconnect with our old partners. Although the agencies have drifted apart for a brief period, the com- panies’ commitment to delivering high- quality medication to patients have brought us together once again.”
